VIVO - Meridian Bioscience, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue9/30/20189/30/20179/30/20169/30/2015
Total Revenue213,571200,771196,082192,930
Cost of Revenue83,11076,47968,87071,048
Gross Profit130,461124,292127,212121,882
Operating Expenses
Research Development16,87016,03614,19112,605
Selling General and Administrative68,95663,48459,48553,217
Non Recurring----
Others----
Total Operating Expenses168,936155,999142,546136,870
Operating Income or Loss44,63544,77253,53656,060
Income from Continuing Operations
Total Other Income/Expenses Net-14,255-8,343-2,892-997
Earnings Before Interest and Taxes44,63544,77253,53656,060
Interest Expense-1,520-1,642-897-897
Income Before Tax30,38036,42950,64455,063
Income Tax Expense6,53114,87218,41519,523
Minority Interest----
Net Income From Continuing Ops23,84921,55732,22935,540
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income23,84921,55732,22935,540
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares23,84921,55732,22935,540